STEINERT DISEASE
Clinical trials for STEINERT DISEASE explained in plain language.
Never miss a new study
Get alerted when new STEINERT DISEASE trials appear
Sign up with your email to follow new studies for STEINERT DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for muscle disease: new drug enters final testing phase
Disease control OngoingThis study tests a new medicine called AOC 1001 for people with myotonic dystrophy type 1, a genetic disease that causes muscle weakness and stiffness. About 159 adults with a confirmed diagnosis will receive either the drug or a placebo by IV. The main goal is to see if the drug…
Matched conditions: STEINERT DISEASE
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Hope for DM1: new drug tested for long-term safety
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety and effects of a drug called AOC 1001 in people with myotonic dystrophy type 1 (DM1), a genetic muscle disease. About 230 adults who already took part in earlier AOC 1001 studies will receive the drug intravenously. The main goal is to tra…
Matched conditions: STEINERT DISEASE
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 11, 2026 20:49 UTC